KEVIN SIMMONS: Open Payments
NPI 1255479887 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 8 payments from 4 companies in 2025. Trend: 2023 $197 · 2024 $36 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: UZEDY, CAPLYTA, TRINTELLIX, Auvelity.
Industry payments across TX — which companies pay providers there.
